[PE33-7] Omalizumab to prevent exacerbations in children and adolescents with moderate-to-severe allergic asthma: an overview of systematic reviews
The password to see abstracts was announced to registrants by email.
Cancelled
Poster Session
Internal Medicine
The password to see abstracts was announced to registrants by email.